Recent Advances in Mupirocin Delivery Strategies for the Treatment of Bacterial Skin and Soft Tissue Infection
Open Access
- 20 December 2021
- journal article
- review article
- Published by MDPI AG in Future Pharmacology
- Vol. 1 (1) , 80-103
Abstract
Skin and soft tissue infections (SSTIs) have increased problematically in hospital and ambulatory settings due to the poor immunity of hosts and multidrug-resistant pathogens. Mupirocin (MUP), a global topical antibiotic, is used for the treatment of SSTIs caused by various pathogens due to its unique mechanism of action. However, the therapeutic efficiency of MUP is hampered due to the protein binding and drug resistance caused by frequent use. A combined report covering the various aspects of MUP, such as the synthesis of the novel formulation, loading of the drug, and application against various skin infections, is missing. This comprehensive review focuses on various novel drug delivery strategies such as composite biomaterials/scaffold, hydrogel dressings, liposomes, liposomal hydrogel, microparticles/microspheres, microsponges, nanocapsules, nanofibers, silicone-based adhesive patches, and topical sprays. The therapeutic effect of the MUP can be synergized by combining with other agents and using novel strategies. The objective is to enhance patient compliance, decrease the resistance, magnify the delivery of MUP, and overcome the limitations of conventional formulations. Moreover, the carriers/dressing materials are biocompatible, biodegradable, stimulate wound healing, protect the wound from external environmental contamination, adsorb the wound exudates, and are permeable to oxygen and moisture. This review will help researchers to explore further the treatment of various bacterial skin infections by using MUP-loaded novel formulations with better efficacy, utilizing the novel nanostructures or combinatorial methods.Keywords
This publication has 88 references indexed in Scilit:
- Liposomes-in-Hydrogel Delivery System with Mupirocin:In VitroAntibiofilm Studies andIn VivoEvaluation in Mice Burn ModelBioMed Research International, 2013
- Nanocarriers and nanoparticles for skin care and dermatological treatmentsIndian Dermatology Online Journal, 2013
- Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer DrugAAPS PharmSciTech, 2011
- Spray dried microparticles for controlled delivery of mupirocin calcium: Process–tailored modulation of drug releaseJournal of Microencapsulation, 2011
- A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandagesPolymers for Advanced Technologies, 2009
- Trends in US Hospital Admissions for Skin and Soft Tissue InfectionsEmerging Infectious Diseases, 2009
- Development of Microsponges for Topical Delivery of MupirocinAAPS PharmSciTech, 2009
- A Practical Guide to the Treatment of Complicated Skin and Soft Tissue InfectionsDrugs, 2003
- Ampicillin/Sulbactam and Cefoxitin in the Treatment of Cutaneous and Other Soft-Tissue Abscesses in Patients With or Without Histories of Injection Drug AbuseClinical Infectious Diseases, 2000
- Use of mupirocin ointment in the treatment of secondarily infected dermatosesJournal of the American Academy of Dermatology, 1990